Aprea Therapeutics Inc (APRE)
5.19
-0.11
(-2.06%)
USD |
NASDAQ |
May 28, 16:00
4.99
-0.20
(-3.85%)
After-Hours: 20:00
Aprea Therapeutics Cash and Short Term Investments (Quarterly): 32.37M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 32.37M |
| December 31, 2023 | 21.61M |
| September 30, 2023 | 25.35M |
| June 30, 2023 | 27.69M |
| March 31, 2023 | 31.00M |
| December 31, 2022 | 28.79M |
| September 30, 2022 | 33.11M |
| June 30, 2022 | 39.06M |
| March 31, 2022 | 47.65M |
| December 31, 2021 | 53.08M |
| September 30, 2021 | 61.43M |
| Date | Value |
|---|---|
| June 30, 2021 | 69.80M |
| March 31, 2021 | 77.62M |
| December 31, 2020 | 89.02M |
| September 30, 2020 | 101.15M |
| June 30, 2020 | 112.86M |
| March 31, 2020 | 122.51M |
| December 31, 2019 | 130.09M |
| September 30, 2019 | 52.33M |
| June 30, 2019 | 60.99M |
| December 31, 2018 | 65.68M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
21.61M
Minimum
Dec 2023
130.09M
Maximum
Dec 2019
60.88M
Average
52.71M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 12.57M |
| Stoke Therapeutics Inc | 178.58M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |
| iBio Inc | 5.302M |